Carlà , M.M.; Savastano, M.C.; Boselli, F.; Giannuzzi, F.; Rizzo, S.
Ranibizumab Port Delivery System in Neovascular Age-Related Macular Degeneration: Where Do We Stand? Overview of Pharmacokinetics, Clinical Results, and Future Directions. Pharmaceutics 2024, 16, 314.
https://doi.org/10.3390/pharmaceutics16030314
AMA Style
Carlà MM, Savastano MC, Boselli F, Giannuzzi F, Rizzo S.
Ranibizumab Port Delivery System in Neovascular Age-Related Macular Degeneration: Where Do We Stand? Overview of Pharmacokinetics, Clinical Results, and Future Directions. Pharmaceutics. 2024; 16(3):314.
https://doi.org/10.3390/pharmaceutics16030314
Chicago/Turabian Style
Carlà , Matteo Mario, Maria Cristina Savastano, Francesco Boselli, Federico Giannuzzi, and Stanislao Rizzo.
2024. "Ranibizumab Port Delivery System in Neovascular Age-Related Macular Degeneration: Where Do We Stand? Overview of Pharmacokinetics, Clinical Results, and Future Directions" Pharmaceutics 16, no. 3: 314.
https://doi.org/10.3390/pharmaceutics16030314
APA Style
Carlà , M. M., Savastano, M. C., Boselli, F., Giannuzzi, F., & Rizzo, S.
(2024). Ranibizumab Port Delivery System in Neovascular Age-Related Macular Degeneration: Where Do We Stand? Overview of Pharmacokinetics, Clinical Results, and Future Directions. Pharmaceutics, 16(3), 314.
https://doi.org/10.3390/pharmaceutics16030314